X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D | 2023-07-03 | ICVX | Holtzman Douglas | Chief Scientific Officer | S - Sale+OE | $8.85 | -16,356 | 292,846 | -5% | -$144,743 | |||||
D | 2023-04-03 | ICVX | Holtzman Douglas | Chief Scientific Officer | S - Sale+OE | $6.09 | -20,443 | 292,846 | -7% | -$124,407 | |||||
M | 2023-02-13 | ICVX | Holtzman Douglas | Chief Scientific Officer | S - Sale | $10.33 | -4,871 | 292,846 | -2% | -$50,338 | |||||
2022-12-15 | ICVX | Holtzman Douglas | Chief Scientific Officer | S - Sale | $11.14 | -19,648 | 296,050 | -6% | -$218,963 | ||||||
M | 2022-07-29 | ICVX | Holtzman Douglas | Chief Scientific Officer | S - Sale | $6.67 | -10,375 | 315,698 | -3% | -$69,168 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |